双膦酸盐类药物治疗原发性骨质疏松症的胃肠道安全性比较：网状Meta分析——对帕齐亚纳斯和亚伯拉罕森的回复 - Suppr

Suppr

超能文献

Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis-reply to Pazianas and Abrahamsen.

作者信息

Tadrous M, Mamdani M M, Juurlink D N, Krahn M D, Lévesque L E, Cadarette S M

机构信息

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, M5S 3M2, Canada,

出版信息

Osteoporos Int. 2014 Nov;25(11):2671-2. doi: 10.1007/s00198-014-2789-z. Epub 2014 Jul 18.

DOI:10.1007/s00198-014-2789-z

PMID:25035138

Abstract

摘要

相似文献

Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis-reply to Pazianas and Abrahamsen.双膦酸盐类药物治疗原发性骨质疏松症的胃肠道安全性比较：网状Meta分析——对帕齐亚纳斯和亚伯拉罕森的回复

Osteoporos Int. 2014 Nov;25(11):2671-2. doi: 10.1007/s00198-014-2789-z. Epub 2014 Jul 18.

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.对塔德罗斯等人的评论：双膦酸盐类药物在原发性骨质疏松症中的胃肠道安全性比较：一项网状荟萃分析

Osteoporos Int. 2014 Nov;25(11):2669. doi: 10.1007/s00198-014-2788-0. Epub 2014 Jul 18.

Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.双膦酸盐类药物治疗原发性骨质疏松症的胃肠道安全性比较：一项网状Meta分析

Osteoporos Int. 2014 Apr;25(4):1225-35. doi: 10.1007/s00198-013-2576-2. Epub 2013 Nov 28.

Safety of bisphosphonates in the treatment of osteoporosis.双膦酸盐类药物治疗骨质疏松症的安全性。

Am J Med. 2009 Feb;122(2 Suppl):S22-32. doi: 10.1016/j.amjmed.2008.12.004.

Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference.双膦酸盐的胃肠道和肾脏副作用：区分无差异证据和无差异证明。

J Endocrinol Invest. 2015 Feb;38(2):189-92. doi: 10.1007/s40618-014-0211-5. Epub 2014 Nov 21.

Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials.口服双膦酸盐治疗骨质疏松症不会增加严重胃肠道副作用的风险：一项随机对照试验的荟萃分析。

Front Endocrinol (Lausanne). 2020 Nov 10;11:573976. doi: 10.3389/fendo.2020.573976. eCollection 2020.

[Adverse events of drugs for the treatment of osteoporosis].[治疗骨质疏松症药物的不良事件]

Nihon Rinsho. 2007 Oct 28;65 Suppl 8:304-10.

Comment on Pazianas et al.: lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.对帕齐亚纳斯等人的评论：以颌骨手术作为替代指标时，口服双膦酸盐与骨坏死之间不存在关联。

Osteoporos Int. 2008 Jun;19(6):849-50; author reply 851. doi: 10.1007/s00198-007-0546-2.

Bisphosphonates in the treatment of osteoporosis.双膦酸盐类药物在骨质疏松症治疗中的应用。

Endocrinol Metab Clin North Am. 2012 Sep;41(3):487-506. doi: 10.1016/j.ecl.2012.04.007. Epub 2012 Jun 9.

A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.含氮双膦酸盐帕米膦酸、阿仑膦酸和奥帕膦酸对人体胃肠道影响的比较。

J Clin Pharmacol. 2006 Apr;46(4):483-7. doi: 10.1177/0091270006286781.

引用本文的文献

Fabrication, assessment, and optimization of alendronate sodium nanoemulsion-based injectable gel formulation for management of osteoporosis.阿仑膦酸钠纳米乳注射用凝胶制剂的制备、评价及优化及其在骨质疏松症治疗中的应用。

Drug Deliv. 2023 Dec;30(1):2164094. doi: 10.1080/10717544.2022.2164094.

Treatment of Glucocorticoid-Induced Osteoporosis with Bisphosphonates Alone, Vitamin D Alone or a Combination Treatment in Eastern Asians: A Meta-Analysis.仅用双膦酸盐、单独用维生素 D 或联合治疗治疗东亚糖皮质激素诱导的骨质疏松症：一项荟萃分析。

Curr Pharm Des. 2019;25(14):1653-1662. doi: 10.2174/1381612825666190619125426.

Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis.采用质量源于设计方法优化影响载有阿仑膦酸钠用于骨质疏松症的可生物降解肌肉内原位凝胶特性的制剂变量。

PLoS One. 2018 Jun 1;13(6):e0197540. doi: 10.1371/journal.pone.0197540. eCollection 2018.

本文引用的文献

Osteoporos Int. 2014 Nov;25(11):2669. doi: 10.1007/s00198-014-2788-0. Epub 2014 Jul 18.

Osteoporos Int. 2014 Apr;25(4):1225-35. doi: 10.1007/s00198-013-2576-2. Epub 2013 Nov 28.

Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection.解读不一致的间接和多次治疗比较荟萃分析：直接作用抗病毒药物治疗慢性丙型肝炎感染的评估。

Clin Epidemiol. 2013 Jun 20;5:173-83. doi: 10.2147/CLEP.S44273. Print 2013.

Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review.网状Meta 分析报告中系统评价过程分析：方法学系统评价。

BMJ. 2013 Jul 1;347:f3675. doi: 10.1136/bmj.f3675.

Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.健康保健决策中的间接治疗比较和网络荟萃分析解读：ISPOR 间接治疗比较良好实践工作组报告：第 1 部分。

Value Health. 2011 Jun;14(4):417-28. doi: 10.1016/j.jval.2011.04.002.

Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older.唑来膦酸 5 毫克每年一次静脉注射用于预防 75 岁及以上老年骨质疏松绝经后妇女骨折的疗效和安全性。

J Am Geriatr Soc. 2010 Feb;58(2):292-9. doi: 10.1111/j.1532-5415.2009.02673.x. Epub 2010 Jan 8.

Adverse effects of bisphosphonates: implications for osteoporosis management.双膦酸盐的不良反应：对骨质疏松症管理的影响。

Mayo Clin Proc. 2009 Jul;84(7):632-7; quiz 638. doi: 10.1016/S0025-6196(11)60752-0.

The medical dictionary for regulatory activities (MedDRA).监管活动医学词典（MedDRA）。

Drug Saf. 1999 Feb;20(2):109-17. doi: 10.2165/00002018-199920020-00002.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验